Health
Explainer
Major Meta-Analysis Finds Echinacea Significantly Reduces Antibiotic Use for Respiratory Infections
5 sources · 74d ago
Explainer
The Evidence Pack: How the First Embryonic Stem Cell Therapy for Huntington's Disease Aims to Repair the Brain
4 sources · 74d ago
Explainer
Landmark Trial Finds Safer, Equally Effective Antibiotics to Replace Standard Treatment for Deadly 'Golden Staph' Bloodstream Infections
5 sources · 74d ago
More in Health
Research BriefLongevity Science
The Evidence Pack: How GLP-1 Receptor Agonists Reduce Biological Age on Epigenetic Clocks
Longevity Medicine Advocates 40%Clinical Skeptics 35%Trial Investigators 25%
4 sources · 74d ago
ExplainerADHD Innovation
The Evidence Pack: How the First-in-Class NDSRI Centanafadine Treats ADHD Without Exacerbating Anxiety
Clinical Psychiatrists 40%Neuropharmacologists 30%Patient Advocacy Groups 30%
5 sources · 74d ago
ExplainerPeptide Therapy
The Evidence Pack: How the Anti-Aging Peptide Epitalon Works as it Clears a Major FDA Hurdle
Longevity Researchers 40%Regulatory Agencies 35%Endocrinologists 25%
6 sources · 74d ago
ExplainerMetabolic Health
FDA Approves Foundayo, the First Oral GLP-1 Drug That Can Be Taken Without Food or Water Restrictions
Endocrinologists 40%Health Economists 30%Pharmacologists 30%
3 sources · 74d ago
Bone HealthEvidence Review
Routine Calcium and Vitamin D Supplements Found Ineffective for Preventing Fractures in Massive Clinical Review
Clinical Researchers 40%Primary Care Physicians 35%Public Health Advocates 25%
5 sources · 74d ago
Deep DiveGeroscience
The Evidence Pack: How Three FDA-Approved Drugs Are Being Tested to Slow Human Aging
Geroscience Researchers 45%Clinical Skeptics 35%Public Health Advocates 20%
6 sources · 74d ago
ExplainerPsychiatric Medicine
FDA Approves Cobenfy for Schizophrenia and Bipolar I Disorder, Marking First New Mechanism in Decades
Clinical Psychiatrists 40%Neuropharmacologists 35%Patient Advocates 25%
5 sources · 74d ago
Deep DiveVagus Nerve
Invasive Vagus Nerve Stimulation Shows Sustained Two-Year Remission in Severe Treatment-Resistant Depression
Clinical Researchers 40%Patients & Advocates 30%Healthcare Payers 30%
3 sources · 74d ago
ExplainerCardiovascular Health
FDA Approves Baxdrostat, a First-in-Class Aldosterone Inhibitor, for Hard-to-Treat Hypertension
Cardiovascular Researchers 40%Clinical Nephrologists 35%Public Health Advocates 25%
4 sources · 75d ago
ExplainerPancreatic Cancer
The Evidence Pack: How a RAS-Targeted Drug Nearly Doubled Survival in Advanced Pancreatic Cancer
Clinical Oncologists 40%Research Scientists 35%Industry Analysts 25%
5 sources · 75d ago
Deep DiveCellular Reprogramming
The Evidence Pack: How Partial Cellular Reprogramming is Entering Human Trials to Reverse Vision Loss
Longevity Researchers 40%Clinical Ophthalmologists 35%Safety & Bioethics Monitors 25%
5 sources · 75d ago
ExplainerRNA Therapeutics
The Evidence Pack: How a Novel RNA Drug Became the First to Reduce Pancreatitis Risk in Severe Hypertriglyceridemia
Clinical Lipidologists 40%RNA Therapeutics Researchers 35%Patient Advocacy Groups 25%
3 sources · 75d ago
ExplainerCeliac Pipeline
The Evidence Pack: How New Therapies Are Moving Celiac Disease Beyond the Gluten-Free Diet
Clinical Researchers 35%Patient Advocates 35%Factlen Editorial 30%
2 sources · 75d ago
ExplainerNutritional Psychiatry
The Evidence Pack: How Saffron Supplementation Matches SSRIs in Treating Mild-to-Moderate Depression
Integrative Psychiatrists 35%Clinical Researchers 35%Nutraceutical Regulators 30%
3 sources · 75d ago
ExplainerAddiction Medicine
The Evidence Pack: How GLP-1 Drugs Are Being Repurposed to Treat Alcohol Use Disorder
Addiction Researchers 40%Clinical Psychiatrists 35%Factlen Editorial Analysis 25%
4 sources · 75d ago
ExplainerBarrier Repair
The Evidence Pack: How Ectoin and 'Preferential Exclusion' Are Rewriting Skin Barrier Repair
Cellular Biologists 35%Clinical Dermatologists 35%Cosmetic Chemists 30%
4 sources · 75d ago
ExplainerCognitive Science
The Evidence Pack: How L-Theanine Alters Brain Waves to Induce 'Calm Focus'
Neuroscience Researchers 41%Cognitive Performance Analysts 35%Clinical Skeptics 24%
8 sources · 75d ago
ExplainerSkincare Science
The Evidence Pack: How Copper Peptides (GHK-Cu) Actually Work to Rebuild Skin Collagen
Clinical Researchers 40%Barrier-First Estheticians 35%Formulation Chemists 25%
3 sources · 75d ago
ExplainerRespiratory Health
The Evidence Pack: How Nasal Breathing and Nitric Oxide Optimization Transform Sleep and Cardiovascular Health
Pulmonology & Cardiovascular Researchers 40%Sleep Medicine Specialists 40%Dental & Preventative Health Advocates 20%
4 sources · 75d ago
ExplainerChronic Pain
The Evidence Pack: How Pain Reprocessing Therapy is Rewiring the Brain to Eliminate Chronic Pain
Neuroscience Researchers 40%Mind-Body Practitioners 35%Traditional Pain Specialists 25%
5 sources · 75d ago
Deep DiveCellular Aging
The Evidence Pack: How GlyNAC Supplementation Reverses Multiple Hallmarks of Biological Aging
Longevity Researchers 40%Clinical Skeptics 30%Geriatric Medicine Specialists 30%
5 sources · 75d ago
Research BriefPhage Therapy
The Evidence Pack: How Synthetic Bacteriophages Are Defeating Antibiotic-Resistant Superbugs
Clinical Microbiologists 41%Synthetic Biologists 35%Regulatory Experts 24%
6 sources · 75d ago
ExplainerCognitive Health
The Science of Olfactory Enrichment: How Nightly Scents Can Dramatically Boost Memory
Neurobiology Researchers 45%Preventative Wellness Advocates 35%Clinical Skeptics 20%
3 sources · 75d ago
Blindspot
Important stories the mainstream barely covered
High-impact news with only 1–3 outlets covering it. These stories matter — they just didn't make the radar.